MedPath

Anfibatide

Generic Name
Anfibatide
Drug Type
Biotech
CAS Number
1622134-89-7
Unique Ingredient Identifier
DCG29J773G

Overview

Anfibatide is under investigation in clinical trial NCT01585259 (Anfibatide Phase Ib-IIa Clinical Trial).

Background

Anfibatide is under investigation in clinical trial NCT01585259 (Anfibatide Phase Ib-IIa Clinical Trial).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1
Suspended
Posted: 2020/05/28
Sponsor:
Lee's Pharmaceutical...
Phase 2
Posted: 2015/07/13
Sponsor:
Lee's Pharmaceutical...
Phase 1
Completed
Posted: 2012/04/30
Sponsor:
Lee's Pharmaceutical...
Phase 1
Completed
Posted: 2012/04/25
Sponsor:
Lee's Pharmaceutical...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath